Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › In vitro and in vivo enrichment strategy targeting lymphocytes derived from vector transduced HSCs for therapy of disorders

In vitro and in vivo enrichment strategy targeting lymphocytes derived from vector transduced HSCs for therapy of disorders

US Patent 11597917 · Granted Mar 7, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Conditioning agents for use in allogeneic hematopoietic stem cell transplantatio2025
Anti-CD30 and anti-CD3 bispecific antibodies and methods of immunotherapy for CD2025
Gene editing of CAR-T cells for the treatment of T cell malignancies with chimer2025
Anti-CD30 antibodies2025
Suppression of cytokine release syndrome in chimeric antigen receptor cell thera2025
Use of lentivector-transduced T-Rapa cells for amelioration of lysosomal storage2025
Use of lentivector-transduced T-Rapa cells for amelioration of lysosomal storage2025
T-Rapa cells as novel effector cell type for chimeric antigen receptor therapy2024
Recombinant PD-L1 peptides and methods of use2024
Methods and compositions for treatment of cancer2023
CD30 bispecific antibodies and method of immunotherapy of CD30+ malignancies2023
Anti-CD30 antibodies and methods for treating CD30+ cancer2023